CRA International, Inc. (CRAI) Stock Price & Analysis
CRA International, Inc. (CRAI) closed at USD 200.14 on Friday, October 23, 2026, down 0.40% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 200.94; the Oct 23, 2026 session ranged USD 196.53–202.05 on volume of 140,331 shares. Market capitalization is $1.26B, with a 52-week range of USD 132.17–227.29 (NMS). Source: Nexqual, retrieved October 24, 2026 at 14:09 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CRAI.md
Key facts (CRAI)
- Last four reported quarters (through Jul 4, 2026): revenue $795M, net income $49.3M (6.2% margin), free cash flow -$27.7M (SEC filings).
- Valuation: P/E 25.5x (avg 23.1x at the last 3 fiscal year-ends).
- 1 of 80 tracked superinvestors hold CRAI (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (2 analysts), mean target USD 250.5 (range 245–256).
- Total return with dividends: 1Y +7.8% vs S&P 500 +13.4%; 5Y +94.2% vs S&P 500 +76.9%.
- Next earnings: 2026-11-05, EPS estimate USD 2.07, revenue estimate $199M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CRAI)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $566M | $591M | $624M | $687M | $752M | $795M |
| Operating income | $55.7M | $58.7M | $57.5M | $70.8M | $83.1M | $79.4M |
| Net income | $41.7M | $43.6M | $38.5M | $46.7M | $54.8M | $49.3M |
| EPS (diluted) | $5.45 | $5.91 | $5.39 | $6.74 | $8.14 | — |
| Free cash flow | $73.1M | $21.3M | $57.7M | $33.1M | $18.6M | -$27.7M |
| Operating margin | 9.8% | 9.9% | 9.2% | 10.3% | 11.1% | 10.0% |
| Net margin | 7.4% | 7.4% | 6.2% | 6.8% | 7.3% | 6.2% |
| Revenue growth | +11.3% | +4.4% | +5.6% | +10.2% | +9.3% | — |
| Cash + short-term investments | $66.1M | $31.4M | $45.6M | $26.7M | $18.2M | — |
Fiscal years end Jan. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jul 4, 2026) (CRAI)
P/E 25.5x · P/S 1.6x · P/B 6.9x · FCF yield -2.21% · Earnings yield 3.92% · Dividend yield (paid, TTM) 1.15% · Buyback yield (TTM) 4.24%
P/E at fiscal year-ends: Jan 2026 23.2x, Dec 2024 27.7x, Dec 2023 18.3x.
Superinvestors (SEC 13F-HR, Q2 2026) (CRAI)
1 of 80 tracked investors hold CRAI. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Third Avenue Management | 0.47% | $3.0M | New position |
Analysts (CRAI)
Consensus Buy (mean 2.00 on a 1–5 scale), 2 analysts; mean target USD 250.5 (low 245, high 256).
Total return (dividends reinvested) (CRAI)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +7.8% | +94.2% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +7.8% | +14.2% |
| Volatility (annualized) | 39.8% | 34.6% |
| Max drawdown | -38.1% (Jan 2026→May 2026) | -36.2% (Jan 2026→May 2026) |
CRAI revenue by region (quarter ended Jul 4, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| United States | $165.2M | 78.4% | +8.9% |
| United Kingdom | $30.1M | 14.3% | +34.1% |
| Other | $15.5M | 7.3% | +22.2% |
| Total revenue | $210.8M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
CRAI analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $2.07 | $2.19 | -5.5% | $199.0M | 3 |
| Next quarter (ends Dec 2026) | $2.24 | $2.27 | -1.2% | $203.5M | 3 |
| Current fiscal year (ends Dec 2026) | $8.47 | $8.60 | -1.5% | $814.3M | 3 |
| Next fiscal year (ends Dec 2027) | $9.56 | $9.63 | -0.7% | $847.0M | 3 |
Key Statistics (as of October 24, 2026 at 14:09 UTC)
| Price | USD 200.14 |
|---|---|
| Change | ▼ 0.40% (down) |
| Previous Close | USD 200.94 |
| Open | USD 199.55 |
| Day Range | USD 196.53 – 202.05 |
| 52-Week Range | USD 132.17 – 227.29 |
| Volume | 140,331 shares |
| Market Cap | $1.26B |
| Exchange | NMS |
Technical Analysis (CRAI)
Nexqual's technical model rates CRAI "BUY" based on 5 bullish and 3 bearish signals across 127 daily candles, as of October 24, 2026 at 14:09 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 77.99 (overbought) |
| vs SMA50 | Above (USD 171.8) |
| MACD | 6.22 (positive) |
Analyst Ratings (CRAI)
Wall Street analysts rate CRAI "Buy" based on 2 analysts, with a mean price target of USD 250.5 (range USD 245–256), per Nexqual as of October 24, 2026 at 14:09 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 250.5 |
| High Target | USD 256 |
| Low Target | USD 245 |
| Buy / Hold / Sell | 1 / 1 / 0 |
Earnings (CRAI)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 2.07 |
| Revenue Estimate | $199.04M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 2.16 vs est 2.15 ▲ beat |
| 2026-03-31 | USD 1.99 vs est 2.02 ▼ miss |
| 2025-12-31 | USD 2.06 vs est 2.07 ▼ miss |
| 2025-09-30 | USD 2.06 vs est 1.8 ▲ beat |
Source: Nexqual, October 24, 2026 at 14:09 UTC.
Financials & Fundamentals (CRAI)
| Total Revenue | $794.64M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +12.80% |
| Gross Margin | +29.00% |
| Operating Margin | +11.17% |
| Profit Margin | +6.20% |
| ROE | +26.02% |
| Debt / Equity | 1.67 |
| Current Ratio | 0.82 |
| Total Cash | $21.44M |
| Total Debt | $303.65M |
| Free Cash Flow (last four quarters to Jul 2026, SEC 10-Q / 10-K) | -$27.75M (-3.5% of revenue) |
Source: Nexqual, October 24, 2026 at 14:09 UTC.
Financial Health Score (CRAI)
Nexqual rates CRA International, Inc.'s overall financial health "Mixed" across five dimensions, as of October 24, 2026 at 14:09 UTC.
| Growth | Solid — Revenue +9% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 29%, operating 11% (last 12 months) |
| Balance Sheet | Critical — $21M cash vs $304M debt |
| Cash Flow | Weak — FCF negative: -$28M (last 4 quarters to Jul 2026, SEC), burning cash |
| Efficiency | Strong — ROE 26%, ROA 7.7% |
Ownership (CRAI)
| Insider Ownership | +3.74% |
|---|---|
| Institutional Ownership | +95.45% |
| Shares Outstanding | 6.28M |
| Float | 6.04M |
| Short % of Float | +4.77% |
Source: Nexqual, October 24, 2026 at 14:09 UTC.
Leadership (CRAI)
CRA International, Inc. is led by Paul A. Maleh, Chairman, President & CEO, per Nexqual as of October 24, 2026 at 14:09 UTC.
| Chairman, President & CEO | Paul A. Maleh |
|---|---|
| Executive VP, CFO & Treasurer | Eric R. Nierenberg |
| Executive VP, Chief Strategy & Business Transformation Officer | Brian Langan |
| VP & Director of Operations | Mary Beth Savio |
| VP & Global Chief Marketing Officer | Graham Ross |
Major Backers & Investors (CRAI)
Notable institutional backers of CRA International, Inc. include FMR, LLC, Fidelity, Two Sigma Investments, LP, according to Nexqual as of October 24, 2026 at 14:09 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 7.49% |
| Fidelity | 5.17% |
| Two Sigma Investments, LP | 4.17% |
| Needham Investment Management, L.L.C. | 3.43% |
| Needham Funds Inc-Needham Aggressive Growth Fund | 3.41% |
| Renaissance Technologies | 2.9% |
| Point72 Asset Management, L.P. | 2.87% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 10.24% |
| Vanguard Group | 4.42% |
| Dimensional Fund Advisors | 3.11% |
Source: Nexqual, October 24, 2026 at 14:09 UTC.
From CRA International, Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)
Key Strengths & Strategy (as disclosed to the SEC)
- We have worked with leading law firms across the globe and believe we have developed a reputation among law firms as a preferred source of sophisticated economic advice for litigation and regulatory work.
- Since our inception in 1965, we have been engaged by clients for our unique combination of functional expertise and industry knowledge, and for our objective solutions to complex problems.
- Our analytical strength enables us to reach objective, factual conclusions that help clients make important business and policy decisions and resolve critical disputes.
- We believe our ability to combine expertise in advanced economic and financial methods with in-depth knowledge of particular industries is one of our key competitive strengths.
Legal & Regulatory Risks (Item 1A, quoted)
- We are subject to income and other taxes in the U.S. at the state and federal level and also in foreign jurisdictions. Changes in applicable U.S. state, federal or foreign tax laws and regulations, or their interpretation and application, could materially affect our tax expense and profitability.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ICFI | ICF International, Inc. | USD 94.4 | ▲ 1.15% |
| SBC | SBC Medical Group Holdings Inco | USD 5.28 | ▼ 7.21% |
| HURN | Huron Consulting Group Inc. | USD 195.69 | ▲ 1.21% |
| FCN | FTI Consulting, Inc. | USD 157.24 | ▼ 0.22% |
| ROMA | Roma Green Finance Limited | USD 6 | ▼ 12.08% |
| BAH | Booz Allen Hamilton Holding Cor | USD 78.32 | ▼ 0.32% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 14:09 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt